Volume 39, Issue 2 (8-2015)                   Research in Medicine 2015, 39(2): 92-98 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mahmoudian E, Khalilnezhad A, Mahmoodi F, Gharagozli K, Amani D. Relation of multiple sclerosis and interferon-beta consumptionwith expression of thioredoxin Trx 1. Research in Medicine. 2015; 39 (2) :92-98
URL: http://pejouhesh.sbmu.ac.ir/article-1-1382-en.html
Associate Professor Department of Immunology, Medical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran , amanid@sbmu.ac.ir
Abstract:   (2635 Views)

Background: Regarding the increasing incidence of multiple sclerosis (MS), importance of biomarkers, and also the probable changes in expression of Trx1 gene in this disease, herein we investigated mRNA expression level of Trx1 gene in peripheral blood leukocytes of patients with MS, receiving no medications and those receiving .interferon beta, relative to healthy individuals Methods: Six healthy subjects, as control, and 12 patients with multiple sclerosis, divided into two groups of patients without medications (n=6) and interferon-beta receiving patients (n=6), were included in the study. The numbers of Trx1 mRNA transcripts in two groups of the patients was measured by SYBR green real-time PCR .technique, and compared relative to those of healthy individuals Results: The mRNA expression of Trx1 in patients without medications was about 1.98 folds higher relative to the healthy controls. However, this difference was not statistically significant (p > 0.05). Also, the mRNA expression of Trx1 in interferon-beta receiving patients exhibited an insignificant increase (p > 0.05) relative to that of healthy .(controls and patients without medications (3.28 and 1.66 folds, respectively Conclusion: According to our results, the expression of Trx1 gene seems to be a suitable index for MS especially in the patients receiving interferon beta. However, more remains to be elucidated in support of this hypothesis through large-sample size studies. Also, the possible effect of other medications followed by MS patients including .immunosuppressive drugs is suggested to receive attention in future investigations

Full-Text [PDF 562 kb]   (1187 Downloads)    
Type of Study: Original | Subject: Immunology
Received: 2015/02/24 | Accepted: 2015/11/28 | Published: 2016/03/6

Send email to the article author

Creative Commons License
This Journal is licensed under a Creative Commons Attribution 4.0 International License  | Research in Medicine

Designed & Developed by : Yektaweb